ACTIO BIOSCIENCES
Actio Biosciences involves in the development of precision medicines for homogenous rare patient populations. They develop a pipeline of new medicines with the goal to enhance the probability of clinical success and deliver medicines for all patients.
ACTIO BIOSCIENCES
Social Links:
Industry:
Bioinformatics Biotechnology Genetics
Founded:
2021-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.actiobiosciences.com
Total Employee:
11+
Status:
Active
Total Funding:
55 M USD
Technology used in webpage:
Euro U.S. Server Location
Similar Organizations
Dimension Therapeutics
Dimension Therapeutics is a gene therapy company developing novel treatments for rare diseases.
iBio
iBio is a technology platform that develops pharmaceutical product applications.
Pacific Northwest Research Institute
Pacific Northwest Research Institute is a research institute for genetics and bioinformatics research.
Prolocor
Prolocor is a biotechnology company that develops diagnostic tests for cardiovascular diseases.
Spark Therapeutics
Spark Therapeutics is focused on the development of gene therapy.
Parse Biosciences
Parse Biosciences is a biotechnology startup company that develops single-cell sequencing kit solutions for researchers.
Tome Biosciences
Tome Biosciences is a biotechnology company that develops programmable gene insertion technology.
TruDiagnostic
TruDiagnostic is a biodata research company that offers epigenetic testing and research services.
Current Advisors List
Current Employees Featured
Founder
Investors List
Canaan Partners
Canaan Partners investment in Series A - Actio Biosciences
Euclidean Capital
Euclidean Capital investment in Series A - Actio Biosciences
Droia Ventures
Droia Ventures investment in Series A - Actio Biosciences
EcoR1 Capital
EcoR1 Capital investment in Series A - Actio Biosciences
Deerfield Management
Deerfield Management investment in Series A - Actio Biosciences
Key Employee Changes
| Date | New article |
|---|---|
| 2024-01-24 | Actio Biosciences Appoints Samuel Collins, MBBS, Ph.D., MBA, as Chief Medical Officer as Company Advances Multiple Precision Medicine Programs Toward Clinical Development |
Official Site Inspections
http://www.actiobiosciences.com Semrush global rank: 5.6 M Semrush visits lastest month: 1.29 K
- Host name: 151.101.66.159
- IP address: 151.101.66.159
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Actio Biosciences"
About • Actio Biosciences
Dr. Breckenridge joined Actio Biosciences after a 15-year tenure at Gilead Sciences, where he held multiple leadership roles in research. As the leader of Gilead’s fibrosis department, he …See details»
Actio Biosciences - Crunchbase Company Profile & Funding
Actio Biosciences involves in the development of precision medicines for homogenous rare patient populations. They develop a pipeline of new medicines with the goal to enhance the …See details»
Actio Biosciences, Inc. | LinkedIn
Actio Biosciences, Inc. | 3,078 followers on LinkedIn. From One To Many. | We’re leveraging advances in genetics and precision medicine to develop new therapeutics that target shared, underlying ...See details»
Actio Biosciences - Overview, News & Similar companies - ZoomInfo
Jan 24, 2024 View Actio Biosciences (www.actiobiosciences.com) location in California, United States , revenue, industry and description. Find related and similar companies as well as …See details»
Actio Biosciences, Inc. Company Overview, Contact Details
Aug 20, 2024 actiobiosciences.com. SIC Code 8733 - Noncommercial Research Organizations. NAICS Code 541714 - Research and Development in Biotechnology (except …See details»
Actio Biosciences - PitchBook
Actio Biosciences General Information Description. Developer of a portfolio of drugs designed to cure rare diseases that could also help treat common illnesses. The company's portfolio uses biotechnology that modulates the activity of …See details»
Actio Biosciences Company Profile - Office Locations ... - Craft
Actio Biosciences is a company developing treatments for homogenous rare disease populations by using genetic insights. Its services include drug discovery and development, disease target …See details»
Actio Biosciences Expands Leadership Team with Appointment of …
SAN DIEGO, January 8, 2025 – Actio Biosciences, a biotechnology company leveraging a novel platform approach to genetics and precision medicine to develop new therapeutics that target …See details»
Actio Biosciences - Company Profile - Tracxn
Feb 19, 2025 Actio Biosciences - From One to Many | Actio Biosciences. Raised a total funding of $55M over 1 round from 6 investors. Founded by David B Goldstein in the year 2021. Actio …See details»
Actio Biosciences, Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Actio Biosciences, Inc. of San Diego, CA. Get the latest business insights from Dun & Bradstreet.See details»
Actio Biosciences | Deerfield
Actio Biosciences is a Deerfield-backed company focused on advancing healthcare through innovative biotechnologies.See details»
Actio Biosciences, Inc. Overview | SignalHire Company Profile
Get Emails & Phone numbers for Company Actio Biosciences, Inc.'s employees View contact details for free by signing up. Get up to 10 free lookups monthly.See details»
Actio Biosciences - VentureRadar
Dansk Biotek Unknown n/a DANISH BIOTECH is a trade organization for Danish biotech companies with the aim to promote opportunities for biotechnology research, development and …See details»
Lights, Camera: Actio Biosciences Launches to Bridge Common …
Sep 12, 2023 Lights, Camera: Actio Biosciences Launches to Bridge Common and Rare Disease Treatments. With a $55-million Series A, the San Diego-based company aims to …See details»
Science • Actio Biosciences
Unique Genetics Approach to Maximize Clinical Benefit for Patients. Actio develops transformational medicines for rare diseases with high unmet need by precisely targeting …See details»
Actio Biosciences Raises $55M in Series A Financing
Sep 12, 2023 NEW YORK – Actio Biosciences on Tuesday said it has raised $55 million in Series A financing that it hopes to use to advance precision medicines for rare and common …See details»
Actio Biosciences Announces $55 Million Series A Financing to …
SAN DIEGO, September 12, 2023 – Actio Biosciences, a biotechnology company leveraging a novel platform approach to genetics and precision medicine to develop new therapeutics that …See details»
Actio Biosciences Announces $55 Million Series A Financing to …
Sep 12, 2023 SAN DIEGO--(BUSINESS WIRE)--Actio Biosciences, a biotechnology company leveraging a novel platform approach to genetics and precision medicine to develop new …See details»
Landmark Bio Acquired by Artis BioSolutions to Expand …
2 days ago The organization was established by leaders from academia, industry, and Boston's leading research hospitals. Together with Artis BioSolutions, Landmark Bio will enhance its …See details»
HiveBio selects 10 startups for first life sciences accelerator ...
9 hours ago Here are the members of HiveBio's first cohort for its life sciences accelerator program geared towards underrepresented entrepreneurs.See details»